![Michael Messinger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Messinger
Finanzdirektor/CFO bei
SEASTAR MEDICAL HOLDING CORPORATION
Vermögen: 6 493 $ am 31.05.2026
Profil
Michael Messinger is Director at Filament Health Corp.
since 2024.
Mr. Messinger is Chief Financial Officer at Seastar Medical Holding Corp.
starting in 2025.
Formerly, Mr. Messinger was President, Chief Executive & Operating Officer at ContraFect Corp.
in 2023.
Mr. Messinger was Finance Director at Lexicon Pharmaceuticals, Inc. from 2001 to 2012.
Mr. Messinger was Controller at Coelacanth Corp.
from 1999 to 2001.
Mr. Messinger was Auditor at Ernst & Young LLP from 1996 to 1999.
Mr. Messinger completed undergraduate education at the University of Michigan.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 1’750 ( 0.04% ) | 6 493 $ | 31.05.2026 |
Aktive Positionen von Michael Messinger
| Unternehmen | Position | Beginn |
|---|---|---|
| FILAMENT HEALTH CORP. | Direktor/Vorstandsmitglied | 28.03.2024 |
| SEASTAR MEDICAL HOLDING CORPORATION | Finanzdirektor/CFO | 14.11.2025 |
Ehemalige bekannte Positionen von Michael Messinger
| Unternehmen | Position | Ende |
|---|---|---|
| CONTRAFECT CORPORATION | Vorstandsvorsitzender | 04.12.2023 |
| LEXICON PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 01.01.2012 |
Coelacanth Corp.
 Coelacanth Corp. Miscellaneous Commercial ServicesCommercial Services Researches drug development | Comptroller/Controller/Auditor | 01.01.2001 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Comptroller/Controller/Auditor | 01.01.1999 |
Ausbildung von Michael Messinger
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
58
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Lexicon Pharmaceuticals, Inc.
 Lexicon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Coelacanth Corp.
Coelacanth Corp. Miscellaneous Commercial ServicesCommercial Services Researches drug development | Commercial Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ContraFect Corp.
 ContraFect Corp. BiotechnologyHealth Technology Engages in discovery and development of direct lytic agents for life-threatening & drug-resistant infectious diseases | Health Technology |
Filament Health Corp.
 Filament Health Corp. Pharmaceuticals: OtherHealth Technology Develops psychedelic pharmaceuticals | Health Technology |
Seastar Medical Holding Corp.
 Seastar Medical Holding Corp. Medical SpecialtiesHealth Technology Manufactures medical devices and develops technology solutions | Health Technology |
